BioMarin Pharmaceutical Inc.BMRNNASDAQ
Loading
Year-over-year earnings per share growth rate
Percentile
P36
Within normal range
vs 3Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | -50.00% |
| Q3 2025 | -112.80% |
| Q2 2025 | 28.87% |
| Q1 2025 | 46.97% |
| Q4 2024 | 15.79% |
| Q3 2024 | 1.79% |
| Q2 2024 | 19.15% |
| Q1 2024 | 327.27% |
| Q4 2023 | -47.62% |
| Q3 2023 | -30.00% |
| Q2 2023 | 11.11% |
| Q1 2023 | 20869.23% |
| Q4 2022 | 96.37% |
| Q3 2022 | -123.87% |
| Q2 2022 | -76.19% |
| Q1 2022 | 296.88% |
| Q4 2021 | -60.00% |
| Q3 2021 | -385.71% |
| Q2 2021 | -30.00% |
| Q1 2021 | -16.67% |
| Q4 2020 | -97.23% |
| Q3 2020 | 2806.25% |
| Q2 2020 | -135.56% |
| Q1 2020 | 462.50% |
| Q4 2019 | -74.19% |
| Q3 2019 | 247.62% |
| Q2 2019 | 34.38% |
| Q1 2019 | -1460.98% |
| Q4 2018 | 71.17% |
| Q3 2018 | 25.08% |
| Q2 2018 | 62.04% |
| Q1 2018 | 13.79% |
| Q4 2017 | -305.59% |
| Q3 2017 | 65.95% |
| Q2 2017 | -122.69% |
| Q1 2017 | 82.21% |
| Q4 2016 | -103.85% |
| Q3 2016 | 90.04% |
| Q2 2016 | -392.45% |
| Q1 2016 | -223.26% |